Click Here for Dr. Pressman's Best Case Medicine

Friday, May 18 2012      

Search this site with
 Google
  

 

 

          Article Summary  

Johnson & Johnson Halts Trials of Procrit
(NY, Reuters Health,11/26/03)

Ortho Biotech, a subsidiary of Johnson & Johnson, has suspended clinical trials of Procrit, a drug that stimulates the body to manufacture more oxygen-carrying red blood cells. The company had hoped to introduce the drug as an adjunct to cancer treatments, like radiation or chemotherapy; but found that elevating hemoglobin beyond certain levels resulted in unacceptable levels of blood-clotting. Company spokespeople say that the drug is safe when used at the lower levels appropriate for treating anemia.
 

Disclaimer: SmartTrac Computer Systems, Inc. does not warrant that the information on this website is free of errors, inaccuracies or omissions.  The content of this website is presented for educational purposes only. It is not intended as a substitute for the diagnosis, treatment and advice of a qualified licensed professional.

© 2004-2010, SmartTrac Computer Systems, Inc.  All rights reserved.   The content of Health News Express is the intellectual property of SmartTrac Computer Systems, Inc. Any use of the materials presented on this website is expressly prohibited without prior written consent.